As previously mentioned, MCP-1 participates in progressive renal fibrosis by binding to its receptor, CCR2.[2] This indicates that MCP-1/CCR2 axis seems to be a promising target for treating DN. The gene discussed is CCR2; the disease is liver dysplastic nodule.